DEDICATED TO RARE DISEASES
Dead / Cancelled — Cancelled — Section 8 (as of 22 Apr 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86458964
- Registration number
- 4828804
- Mark type
- Stylized text
- Filed
- 19 Nov 2014
- Published for opposition
- 05 May 2015
- Registered
- 06 Oct 2015
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for rare, terminal, liver and genetic diseases and dyslipidemia
Owner
- ALEXION PHARMACEUTICALS, INC., Boston, MA, US
- Synageva BioPharma Corp., Lexington, MA, US
- Synageva BioPharma Corp., Lexington, MA, US
- Synageva BioPharma Corp., Lexington, MA, US
Prior registrations
Prosecution history
- 22 Apr 2022 — CANCELLED SEC. 8 (6-YR)
- 06 Oct 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Nov 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Nov 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Feb 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Oct 2015 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Aug 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Aug 2015 — USE AMENDMENT FILED
- 19 Aug 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Aug 2015 — TEAS STATEMENT OF USE RECEIVED
- 30 Jun 2015 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 May 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 May 2015 — PUBLISHED FOR OPPOSITION